catalyst · primary record
FDA Press Releases
News catalyst · 2026-10-19 · regulatory-approval, designation
| Company | FDA Press Releases |
|---|---|
| Ticker | Not stated |
| Impact | medium |
| Detail | FDA Approves Immunotherapy That May Allow Certain Patients with Rectal Cancer to Avoid Chemotherapy, Radiation and Surgery |
| Source | FDA Press Releases |
Provenance
- Source: FDA Press Releases
- Fetched at: 2026-10-28T10:37:33.164Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: FDA Press Releases::2026-10-19:FDA Approves Immunotherapy That May Allow Certain Patients with Rectal Cancer to Avoid Chemotherapy, Radiation and Surgery
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.